| Financial Year |
March 31 2023 |
| Monetary Funds |
246,964,388.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
899,924.10 |
| Accounts Receivable |
99,303,288.56 |
| Advances to Suppliers |
10,539,417.80 |
| Other Receivables |
12,045,355.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,893,731.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,990,589.74 |
| Total Current Assets |
478,636,696.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,922,521.70 |
| Investment Properties |
25,339,993.26 |
| Fixed Assetes |
314,539,058.45 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,794,686.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,454,339.71 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
436,689,314.25 |
| Total Assets |
915,326,010.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
76,770,244.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,750,948.29 |
| Taxes Payable |
996,265.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,615,824.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,419,076.97 |
| Other Current Liabilities |
1,031,000.64 |
| Sub-Total of Current Liabilities |
110,894,927.53 |
| Long-term Loans |
203,577,888.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
220,883,534.04 |
| Total Liabilities |
331,778,461.57 |
| Paid-In Capital(Or Share Stock) |
130,000,000.00 |
| Capital Surplus |
230,441,656.55 |
| Surplus Reserve |
28,676,058.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
153,852,283.92 |
| Minority Stockholder's Interest |
40,577,549.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
542,969,998.91 |
| Owner's Equity（Stockholder's Equity） |
583,547,548.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
915,326,010.36 |
